August 21, 2014 4:36 PM ET

Healthcare Providers and Services

Company Overview of Medytox Solutions, Inc.

Company Overview

Medytox Solutions, Inc. provides clinical laboratory blood and urine testing services to physicians, clinics, and rehabilitation facilities in the United States. It primarily offers urine drug toxicology and pain medication monitoring programs. The company’s turn-key urine drug testing program allows physicians to monitor and treat patients. It also provides a Web-based portal to provide laboratory ordering and results to physician customers. The company was formerly known as Casino Players, Inc. and changed its name to Medytox Solutions, Inc. in 2011. Medytox Solutions, Inc. was founded in 2005 and is headquartered in West Palm Beach, Florida.

400 South Australian Avenue

Suite 800

West Palm Beach, FL 33401

United States

Founded in 2005

115 Employees

Phone:

561-855-1626

Fax:

561-328-9303

Key Executives for Medytox Solutions, Inc.

Founder
Age: 69
Total Annual Compensation: $320.2K
Chief Financial Officer and Principal Accounting Officer
Age: 57
Total Annual Compensation: $311.6K
Vice President of Operations
Age: 38
Total Annual Compensation: $352.2K
Chief Executive Officer of The Medytox Laboratories
Age: 55
Total Annual Compensation: $373.5K
Vice President of Business Development
Age: 48
Total Annual Compensation: $133.6K
Compensation as of Fiscal Year 2013.

Medytox Solutions, Inc. Key Developments

Medytox Solutions, Inc. Reports Consolidated Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Medytox Solutions, Inc. reported consolidated unaudited earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported revenues of $20,784,426 compared with $8,602,577 for the same period last year. Income from operations was $5,798,292 compared with $926,777 for the same period last year. Income before income taxes was $5,697,479 compared with $804,077 for the same period last year. Net income attributable to Medytox Solutions common shareholders was $1,988,937 or $0.06 diluted per share compared with $438,912 or $0.02 diluted per share for the same period last year. For the six months, the company reported of $41,846,998 compared with $16,626,336 for the same period last year. Income from operations was $12,662,370 compared with $2,184,233 for the same period last year. Income before income taxes was $12,599,112 compared with $1,851,390 for the same period last year. Net income attributable to Medytox Solutions common shareholders was $5,378,907 or $0.18 diluted per share compared with $853,384 or $0.03 diluted per share for the same period last year.

Medytox Solutions Inc. Announces Unaudited Consolidated Earnings Results for the Quarter Ended March 31, 2014

Medytox Solutions Inc. announced unaudited consolidated earnings results for the quarter ended March 31, 2014. For the quarter, revenues were $21,062,572 compared to $8,023,759 for the first quarter of 2013, which represents an increase of 162%. Income from operations was $6,864,078 compared to $1,257,456 a year ago. Income before income taxes was $6,901,633 compared to $1,047,313 a year ago. Net income attributable to company commons shareholders was $3,389,970 or $0.11 basic and diluted share compared to $414,472 or $0.01 basic and diluted share a year ago.

Medytox Solutions, Inc. Announces Consolidated Earnings Results for the Year Ended December 31, 2013

Medytox Solutions, Inc. announced consolidated earnings results for the year ended December 31, 2013. The Company reported revenues of approximately $52.5 million, which represented an increase of approximately $31.4 million, or 149%, from the approximately $21.1 million in revenues reported for the year ended December 31, 2012. For the 2013 Year, the company reported income from operations of approximately $14.5 million, compared to income from operations of approximately $3.5 million for the 2012 Year. Income before income taxes was $13.8 million against $3.22 million a year ago. Net income from continuing operations was $8.25 million against $2.74 million a year ago. Net income attributable to company was $8.25 million against $2.34 million a year ago. Net income attributable to company common shareholders was $5.65 million or $0.19 per basic and diluted share compared to $2.3 million or $0.07 per basic and diluted share a year ago.

Similar Private Companies By Industry

Company Name Region
Shaklee International, Inc. United States
Stanislaus Surgical Hospital LLC United States
Humana Insurance Of Puerto Rico, Inc. United States
WSI Health, Inc. United States
El Camino Hospital United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
June 5, 2014
Globalone Information Technologies LLC
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Medytox Solutions, Inc., please visit www.medytoxsolutionsinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.